EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025 Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Paris, France (October 9, 2025 - 6:00 pm) – As of September 30, 2025, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as in...
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2025 Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2025 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, France (9 octobre 2025, 18h00) – Au 30 septembre 2025, le capital d’EssilorLuxottica, le leader mondial dans la conception, la fabrication et la distribution de verres ophtalmiques, de montures et de lunettes de soleil, s’établit comme indiqué ci-dessous. 30 ...
EssilorLuxottica: Third-Quarter 2025 Revenue Conference Call Invitation Third-Quarter 2025 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure of inviting you to our Third-Quarter 2025 Revenue Conference Call on: Thursday, October 16, 2025, at 6:30 pm CEST Dial-in telephone access: If you wish to dial into the conference call, please pre-register at the following link to receive the personal credentials (Dial-in numbers, Conference ID and User ID): If you encounter any issue in the pre-regi...
EssilorLuxottica: Third-Quarter 2025 Revenue Conference Call Invitation Third-Quarter 2025 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure of inviting you to our Third-Quarter 2025 Revenue Conference Call on: Thursday, October 16, 2025, at 6:30 pm CEST Dial-in telephone access: If you wish to dial into the conference call, please pre-register at the following link to receive the personal credentials (Dial-in numbers, Conference ID and User ID): If you encounter any issue in the pre-regi...
EssilorLuxottica: Third-Quarter 2025 Revenue Conference Call Invitation Third-Quarter 2025 RevenueConference Call Invitation Mr STEFANO GRASSI, Chief Financial Officer, andMr GIORGIO IANNELLA, Head of Investor Relations,have the pleasure of inviting you to our Third-Quarter 2025 Revenue Conference Call on: Thursday, October 16, 2025, at 6:30 pm CEST Dial-in telephone access: If you wish to dial into the conference call, please pre-register at the following link to receive the personal credentials (Dial-in numbers, Conference ID and User ID): If you encounter any issue in the pre-regi...
LVMH : INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL Société Européenne au capital de 150 042 510 eurosSiège social : 22, avenue Montaigne – 75008 Paris775 670 417 RCS PARISArticles L. 233-8 II du Code de Commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers Code ISIN : FR0000121014 DateNombre total d’actions en circulationNombre total de droits de vote30 septembre 2025500 141 700Total brut de droits de vote : 747 253 969 Total net* de droits de vote : 743 654 648 * Total net = nombre total de droits de vot...
EssilorLuxottica completes acquisition of Optegra EssilorLuxottica completes acquisition of Optegra Paris, France (1 October 2025) – EssilorLuxottica announces that it has successfully completed the from MidEuropa. Under the Optegra, Lexum and Iris brands, Optegra is a fast-growing and highly integrated ophthalmology platform operating an extensive network of over 70 eye hospitals and diagnostic facilities in five key European markets: the UK, Czech Republic, Poland, Slovakia and the Netherlands. A natural fit for EssilorLuxottica’s expanding med-tech portfolio, this acquisition repres...
EssilorLuxottica finalise l’acquisition d’Optegra EssilorLuxottica finalise l’acquisition d’Optegra Paris, France (1er octobre 2025) – EssilorLuxottica annonce la finalisation de auprès de MidEuropa. Avec les marques Optegra, Lexum et Iris, Optegra est une plateforme d'ophtalmologie à forte croissance et hautement intégrée, opérant un vaste réseau de plus de 70 hôpitaux ophtalmologiques et centres de diagnostic dans cinq marchés européens clés : le Royaume-Uni, la République tchèque, la Pologne, la Slovaquie et les Pays-Bas. Très complémentaire avec le portefeuille med-tech d'EssilorLu...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.